|Last Price||Today's Change||52-Week Range||Trading Volume|
|87.02||-0.43 (-0.49%)||69.33 - 263.81||13.1 million (Below Avg)|
Market data as of 4:01PM 11/25/15. Quotes are delayed by at least 15 min.
These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Performed well consistently?||Neutral|
|Avoids excess debt?||Neutral|
|Converting sales to profits?||Neutral|
|Shareholder's money handled rationally?||Neutral|
|Increased shareholder value?||Neutral|
|Consistently increased owner earnings?||Neutral|
|Sells at 25% discount to intrinsic value?||Neutral|
These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Pays a cash dividend?||Neutral|
|Room to increase dividends?||Neutral|
|Increased earnings over time?||Neutral|
|Borrows within reasonable limits?||Neutral|
|Stock is undervalued?||Neutral|
|Have investors caught on?||Neutral|
|Has support of institutional investors?||Neutral|
|Has sufficient liquidity?||Neutral|
Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International
Business Wire - Monday 11/23/2015 5:19 PM ET
VALEANT ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Fund Managers, Institutional and Large Individual Investors with Losses in Excess of $1 million of Lead Plaintiff Deadline in Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc. - VRX
PR Newswire - Friday 11/20/2015 10:00 PM ET
/C O R R E C T I O N -- Valeant Pharmaceuticals International, Inc./
PR Newswire - Friday 11/20/2015 8:00 AM ET
Valeant Pharmaceuticals To Present At Industry Conference
PR Newswire - Thursday 11/12/2015 8:00 PM ET
VRX INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Securities Class Action Against Valeant Pharmaceuticals International, Inc.
Business Wire - Wednesday 11/11/2015 3:36 PM ET
Covered Call Alerts For Relypsa, Qorvo, Invensense, Kinder Morgan and Valeant Pharmaceuticals Released By InvestorsObserver
PR Newswire - Monday 11/09/2015 9:31 AM ET
Valeant To Hold Conference Call For Investors To Provide Business Update
PR Newswire - Monday 11/09/2015 8:00 AM ET
FINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Valeant Pharmaceuticals International, Inc. And Strongly Encourages Investors To Contact The Firm
Business Wire - Saturday 11/07/2015 9:17 PM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.